Paul T Quinlan
CIK 1333277 · General Counsel · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.81M
Companies
3
Total Filings
76
Lifetime Open-Market Net
-$1.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | General Counsel | 31,034 | $90.45 | $2.81M | -$81.4K | 4 | 2026-06-15 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | General Counsel | 0 | $32.48 | $0 | -$1.50M | 18 | 2024-03-22 |
| TerraVia Holdings, Inc. (TVIA) Delisted | General Counsel | 218,403 | — | — | -$58.2K | 5 | 2017-03-13 |
Recent Filings · Page 2 of 8
76 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-15 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$95.2K | EDGAR |
| 2023-11-17 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$72.2K | EDGAR |
| 2023-11-15 | — | Notice (144) | −5,000 | -$86.9K | EDGAR |
| 2023-10-18 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$54.1K | EDGAR |
| 2023-10-16 | — | Notice (144) | −5,000 | -$68.8K | EDGAR |
| 2023-09-19 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | −24,000 | -$808.9K | EDGAR |
| 2023-09-15 | — | Notice (144) | −53,000 | -$894.1K | EDGAR |
| 2023-08-16 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$44.9K | EDGAR |
| 2023-08-15 | — | Notice (144) | −5,000 | -$59.6K | EDGAR |
| 2023-07-14 | — | Notice (144) | −5,000 | -$59.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.